| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Other income, net | 287 | 4,319 | 6,683 | 3,558 |
| Income (loss) before income taxes | 17,112 | 18,215 | -1,149 | 9,027 |
| Income tax provision (benefit) | 2,201 | 3,349 | -495 | 3,314 |
| Net income | 14,911 | 14,866 | -654 | 5,713 |
| Foreign currency translation adjustment | -2,391 | 46,125 | 9,822 | -1,503 |
| Comprehensive income | 12,520 | 60,991 | 9,168 | 4,210 |
| Earnings per share, basic | 0.27 | 0.26 | -0.01 | 0.1 |
| Earnings per share, diluted | 0.26 | 0.26 | -0.01 | 0.1 |
| Weighted average number of shares outstanding, basic | 56,265 | 56,234 | 56,012 | 55,884 |
| Weighted average number of shares outstanding, diluted | 56,532 | 56,510 | 56,012 | 56,434 |
REPLIGEN CORP (RGEN)
REPLIGEN CORP (RGEN)